Kardigan, Inc. Common Stock (KARD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kardigan, Inc. Common Stock (KARD) has a cash flow conversion efficiency ratio of 0.189x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-56.78 Million) by net assets ($-300.63 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Kardigan, Inc. Common Stock to measure how much of total assets are equity-financed.
Kardigan, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2024–2025)
This chart illustrates how Kardigan, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore how well can Kardigan, Inc. Common Stock service its debt to assess how comfortably operating cash covers total debt obligations.
Kardigan, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kardigan, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AG Anadolu Group Holding
IS:AGHOL
|
0.114x |
|
Homeco Daily Needs REIT
AU:HDN
|
0.020x |
|
Allied Blenders & Distillers Ltd
NSE:ABDL
|
N/A |
|
Omnicell Inc
NASDAQ:OMCL
|
0.025x |
|
Beijing Dabeinong Technology Group Co Ltd
SHE:002385
|
0.050x |
|
Isrotel -L
TA:ISRO
|
0.097x |
|
BaoJi Titanium Industry Co Ltd
SHG:600456
|
0.022x |
|
Zhejiang Jinke Peroxides Co Ltd
SHE:300459
|
0.029x |
Annual Cash Flow Conversion Efficiency for Kardigan, Inc. Common Stock (2024–2025)
The table below shows the annual cash flow conversion efficiency of Kardigan, Inc. Common Stock from 2024 to 2025. For the full company profile with market capitalisation and key ratios, see Kardigan, Inc. Common Stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-250.34 Million | $-151.06 Million | 0.603x | +166.67% |
| 2024-12-31 | $-83.19 Million | $-18.82 Million | 0.226x | -- |
About Kardigan, Inc. Common Stock
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI… Read more